16th Nov 2020 10:46
(Alliance News) - Remote Monitored Systems PLC on Monday said its Pharm2Farm Ltd subsidiary has received enquiries from potential distributors of its antiviral face masks.
Shares in the company were 21% higher at 6.04 pence each in London on Monday morning.
The London-based data collection and surveying firm now expects that demand for the face masks may outstrip production capacity, at least until Pharm2Farm has "procured additional production lines".
"Over the weekend P2F signed binding heads of terms with a manufacturer of surgical masks in Germany. The German manufacturer will subcontract to supply complete masks to P2F to the P2F specification and brand name, and also purchase P2F filter material for their own brand masks," Remote Monitored said.
On Tuesday, the company said that news of Pfizer Inc's and BioNTech SE vaccine did not lessen demand for Pharm2Farm's viricidal mask product.
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
RMS.L